Table 4.
Correlation of changes in IGF-1, pain, and pain threshold, and changes in cerebrospinal markers
ΔIGF-1 (serum) | ΔPain threshold | ΔPain | |
---|---|---|---|
0.495 | 0.539 | 0.075 | |
ΔCSF SP | P = 0.072 | P = 0.038 | P = 0.790 |
n = 14 | n = 15 | n = 15 | |
-0.164 | 0.335 | 0.016 | |
ΔCSF NGF | P = 0.558 | P = 0.204 | P = 0.953 |
n = 15 | n = 16 | n = 16 | |
0.802 | 0.288 | 0.315 | |
ΔCSF NPY | P = 0.001 | P = 0.318 | P = 0.273 |
n = 13 | n = 14 | n = 14 | |
-0.165 | 0.225 | -0.119 | |
ΔCSF IL-6 | P = 0.573 | P = 0.420 | P = 0.673 |
n = 15 | n = 15 | n = 15 | |
-0.164 | -0.109 | 0.103 | |
ΔCSF IL-8 | P = 0.558 | P = 0.688 | P = 0.704 |
n = 15 | n = 16 | n = 16 | |
-0.156 | -0.579 | 0.329 | |
ΔCSF MMP3 | P = 0.594 | P = 0.024 | P = 0.231 |
n = 14 | n = 15 | n = 15 |
Median and range (min-max) indicated. Spearmans rho(rs), two-tailed significance (P), and number of subjects (n) are presented.